The North America western blotting market is projected to grow from US$ 257.05 million in 2018 to US$ 404.96 million by 2027, at a compound annual growth rate (CAGR) of 5.4% from 2019 to 2027.
?Download Full PDF Sample Copy of Market Report @
https://wwcw.businessmarketinsights.com/sample/TIPRE00006462
Market growth is primarily driven by increased investments in proteomics research and the rising prevalence of diseases such as Lyme disease and HIV. However, the adoption of alternative protein detection technologies may moderate growth in the coming years.
Western blotting plays a critical role in both diagnostic testing and research by delivering confirmatory results. In North America, Lyme disease—a tick-borne illness—is increasingly prevalent. A 2018 study by Carnegie Mellon University projected a rise in Lyme disease cases across the U.S., attributed largely to climate change. Western blot IgM testing has demonstrated a specificity of 94–96% in diagnosing patients showing clinical symptoms of Lyme disease.
The prevalence of HIV/AIDS has also risen globally in recent years. HIV (human immunodeficiency virus) compromises the immune system and can lead to acquired immunodeficiency syndrome (AIDS), a potentially life-threatening condition. According to the U.S. Department of Health & Human Services and the Secretary’s Minority AIDS Initiative Fund (SMAIF), approximately 36.9 million people were living with HIV/AIDS worldwide in 2017, with the majority residing in low- and middle-income countries. In India, the HIV Estimation 2017 report by the National Informatics Centre reported an HIV prevalence of 0.22% (range: 0.16%–0.30%) among adults, with prevalence among males at 0.25% and females at 0.19%. Western blotting is commonly used to confirm HIV diagnoses following initial screening with ELISA, historically serving as the gold standard for HIV-1 confirmation. According to HIV.gov, approximately 38,700 new HIV infections occurred in the U.S. in 2016 alone.
The United States is expected to lead the North America western blotting market throughout the forecast period. This leadership is attributed to advancements in biotechnology, robust R&D activity in diagnostics, and the country’s position as a major exporter of biotechnology-derived agricultural products. These factors are expected to contribute significantly to the growth of the western blotting market in the region.
North America Western Blotting Strategic Insights
Strategic insights for the North America Western Blotting provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
Market leaders and key company profiles
Thermo Fisher Scientific Inc.
Merck KGaA,
GENERAL ELECTRIC
Cell Signaling Technology, Inc.
PerkinElmer, Inc.
Bio-Rad Laboratories, Inc.
LI-COR, Inc.
OriGene Technologies, Inc.,
Rockland Immunochemicals Inc.
Abcam plc
North America Western Blotting Market – Regional Insights
The geographic scope of the North America Western Blotting market highlights the specific regions where businesses operate and compete. To succeed, companies must understand regional variations such as differing consumer preferences (e.g., demand for certain plug types or backup power durations), economic conditions, and regulatory requirements. Recognizing these distinctions enables businesses to tailor their strategies effectively to local needs. By identifying underserved regions and adapting product offerings accordingly, companies can expand market presence, allocate resources more efficiently, implement targeted marketing campaigns, and strengthen their competitive edge. This localized approach ultimately supports sustained growth across diverse markets in North America.
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Défense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications
Author's Bio
Akshay
Senior Market Research Expert at Business Market Insights
